Brief: Medipharm Labs Enters United States Pharmaceutical Market With Submission Of FDA Dmf
23/02/2022 12:23
Feb 23 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS ENTERS UNITED STATES PHARMACEUTICAL MARKET
WITH
SUBMISSION OF FDA DMF
* MEDIPHARM LABS - COMPLETED A DRUG MASTER FILE PROCESS FOR
CBD
ACTIVE PHARMACEUTICAL INGREDIENT FOR U.S FEDERAL DRUG
ADMINISTRATION
Source text for Eikon: ID:nCNWT77G7a
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue